Trials / Terminated
TerminatedNCT00065117
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the Safety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZD6126 | |
| DRUG | Placebo | |
| DRUG | 5-fluorouracil | |
| DRUG | leucovorin | |
| DRUG | oxaliplatin |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2004-02-01
- Completion
- 2004-02-01
- First posted
- 2003-07-18
- Last updated
- 2011-01-26
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00065117. Inclusion in this directory is not an endorsement.